These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Autologous stem cell transplantation for progressive multiple sclerosis: update of the European Group for Blood and Marrow Transplantation autoimmune diseases working party database. Saccardi R; Kozak T; Bocelli-Tyndall C; Fassas A; Kazis A; Havrdova E; Carreras E; Saiz A; Löwenberg B; te Boekhorst PA; Gualandio F; Openshaw H; Longo G; Pagliai F; Massacesi L; Deconink E; Ouyang J; Nagore FJ; Besalduch J; Lisukov IA; Bonini A; Merelli E; Slavino S; Gratwohl A; Passweg J; Tyndall A; Steck AJ; Andolina M; Capobianco M; Martin JL; Lugaresi A; Meucci G; Sáez RA; Clark RE; Fernandez MN; Fouillard L; Herstenstein B; Koza V; Cocco E; Baurmann H; Mancardi GL; Mult Scler; 2006 Dec; 12(6):814-23. PubMed ID: 17263012 [TBL] [Abstract][Full Text] [Related]
28. Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation. Kashyap A; Snowden J J Rheumatol Suppl; 2001 Oct; 64():39-41. PubMed ID: 11642503 [TBL] [Abstract][Full Text] [Related]
29. High dose chemotherapy followed by autologous haemopoietic stem cell transplant in multiple myeloma. Kumar L; Raju GM; Ganessan K; Shawgi S; Menon H; Wadhwa J; Sharma A; Singh R; Kochupillai V Natl Med J India; 2003; 16(1):16-21. PubMed ID: 12715951 [TBL] [Abstract][Full Text] [Related]
30. Reduced toxicity conditioning and allogeneic stem cell transplantation in adults using fludarabine, carmustine, melphalan, and antithymocyte globulin: outcomes depend on disease risk index but not age, comorbidity score, donor type, or human leukocyte antigen mismatch. Slack JL; Dueck AC; Fauble VD; Sproat LO; Reeder CB; Noel P; Khera N; Betcher JA; Klein JL; Leis JF; Adams RH Biol Blood Marrow Transplant; 2013 Aug; 19(8):1167-74. PubMed ID: 23664940 [TBL] [Abstract][Full Text] [Related]
31. Results of hematopoietic stem cell transplant in Shiraz: 15 years experience in southern Iran. Ramzi M; Nourani H; Zakerinia M; Dehghani M; Vojdani R; Haghshenas M Exp Clin Transplant; 2010 Mar; 8(1):61-5. PubMed ID: 20199373 [TBL] [Abstract][Full Text] [Related]
32. Intense immunosuppressive therapy followed by autologous peripheral blood selected progenitor cell reinfusion for severe autoimmune disease. Musso M; Porretto F; Crescimanno A; Bondi F; Polizzi V; Scalone R Am J Hematol; 2001 Feb; 66(2):75-9. PubMed ID: 11421302 [TBL] [Abstract][Full Text] [Related]
34. [Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC]. Bonnin A; Terriou L; Beuvon C; Tudesq JJ; Puyade M; Pugnet G; Maria A; Llorente CC; Lansiaux P; Cacciatore C; Badoglio M; Yakoub-Agha I; Farge-Bancel D; Marjanovic Z Bull Cancer; 2024 Feb; 111(2S):S84-S95. PubMed ID: 37845095 [TBL] [Abstract][Full Text] [Related]
35. Peripheral T-cell lymphoma: the role of hematopoietic stem cell transplantation. Gkotzamanidou M; Papadimitriou CA Crit Rev Oncol Hematol; 2014 Feb; 89(2):248-61. PubMed ID: 24075060 [TBL] [Abstract][Full Text] [Related]
36. BEAM or BuCyE high-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma patients: a single center comparative analysis of efficacy and toxicity. Kim JE; Lee DH; Yoo C; Kim S; Kim SW; Lee JS; Park CJ; Huh J; Suh C Leuk Res; 2011 Feb; 35(2):183-7. PubMed ID: 20684990 [TBL] [Abstract][Full Text] [Related]
37. High-dose CEB vs BEAM with autologous stem cell transplant in lymphoma. Wang EH; Chen YA; Corringham S; Bashey A; Holman P; Ball ED; Carrier E Bone Marrow Transplant; 2004 Oct; 34(7):581-7. PubMed ID: 15273714 [TBL] [Abstract][Full Text] [Related]
38. Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma. Leger C; Sabloff M; McDiarmid S; Bence-Bruckler I; Atkins H; Bredeson C; Zhang H; Huebsch L Ann Hematol; 2006 Oct; 85(10):723-9. PubMed ID: 16832675 [TBL] [Abstract][Full Text] [Related]
39. Immunoablation followed by autologous hematopoietic stem cell infusion for the treatment of severe autoimmune disease. Rabusin M; Andolina M; Maximova N; Lepore L; Parco S; Tuveri G; Jankovic G Haematologica; 2000 Nov; 85(11 Suppl):81-5. PubMed ID: 11268330 [TBL] [Abstract][Full Text] [Related]
40. Autologous peripheral blood stem cell transplantation as first line treatment of multiple myeloma: an Italian Multicenter Study. Tribalto M; Amadori S; Cudillo L; Caravita T; Del Poeta G; Meloni G; Avvisati G; Petrucci MT; Pulsoni A; Leone G; Sica S; Martelli M; Tabilio A; Fioritoni G; Majolino I; Mandelli F Haematologica; 2000 Jan; 85(1):52-8. PubMed ID: 10629592 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]